EMA Authorised: Zutectra (human hepatitis B immunoglobulin) — Biotest Pharma GmbH

View source ↗

Summary

The European Medicines Agency has authorised Zutectra, a human hepatitis B immunoglobulin, for passive immunization in hepatitis B infection and liver transplan…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Zutectra (human hepatitis B immunoglobulin)

Snippet

Status: Authorised. Therapeutic area: Immunization, Passive;Hepatitis B;Liver Transplantation. MAH: Biotest Pharma GmbH. Decision date: 18/09/2025